📄
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.
active
📄 Paper Details
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.
Shigeta K, Hasegawa M, Hishiki T, Naito Y, Baba Y, Mikami S, Matsumoto K, Mizuno R, Miyajima A, Kikuchi E
Abstract
1. EMBO J. 2023 Feb 15;42(4):e110620. doi: 10.15252/embj.2022110620. Epub 2023 Jan 13. IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. Shigeta K(1), Hasegawa M(2), Hishiki T(3)(4), Naito Y(3), Baba Y(1), Mikami S(5), Matsumoto K(1), Mizuno R(1), Miyajima A(2), Kikuchi E(1)(6), Saya H(3)(7), Kosaka T(1), Oya M(1). Author information: (1)Department of Urology, Keio University School of Medicine, Tokyo, Japan. (2)Department of Urology...
▸Metadata
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
5%
Debates
0
Incoming
1
Outgoing
1
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.